Baseline Urinary Tract Imaging in Infants Enrolled in the UMPIRE Protocol for Children with Spina Bifida
- PMID: 30730412
- PMCID: PMC6625656
- DOI: 10.1097/JU.0000000000000141
Baseline Urinary Tract Imaging in Infants Enrolled in the UMPIRE Protocol for Children with Spina Bifida
Abstract
Purpose: The lifetime risk of renal damage in children with spina bifida is high but only limited baseline imaging data are available for this population. We evaluated a large prospective cohort of infants with spina bifida to define their baseline imaging characteristics.
Materials and methods: The UMPIRE Protocol for Young Children with Spina Bifida is an iterative quality improvement protocol that follows a cohort of newborns at 9 United States centers. Using descriptive statistics, we report the initial baseline imaging characteristics, specifically regarding renal bladder ultrasound, cystogram and dimercaptosuccinic acid nuclear medicine scan.
Results: Data on 193 infants from 2015 to 2018 were analyzed. Renal-bladder ultrasound was normal in 55.9% of infants, while 40.4% had Society for Fetal Urology grade 1 to 2 hydronephrosis in at least 1 kidney, 3.7% had grade 3 to 4 hydronephrosis in either kidney and 21.8% had grade 1 or higher bilateral hydronephrosis. There was no vesicoureteral reflux in 84.6% of infants. A third of enrolled infants underwent dimercaptosuccinic acid nuclear medicine renal scan, of whom 92.4% had no renal defects and 93.9% had a difference in differential function of less than 15%.
Conclusions: The majority of infants born with spina bifida have normal baseline imaging characteristics and normal urinary tract anatomy at birth. This proactive protocol offers careful scheduled surveillance of the urinary tract with the goal of lifelong maintenance of normal renal function and healthy genitourinary development.
Keywords: pediatrics; spinal dysraphism; ultrasonography; urology; vesico-ureteral reflux.
Conflict of interest statement
Comment in
-
Editorial Comment.J Urol. 2019 Jun;201(6):1198. doi: 10.1097/01.JU.0000554373.71979.1e. J Urol. 2019. PMID: 30816835 No abstract available.
References
-
- Sager C, Burek C, Corbett J et al., Initial Urologic Management of children with neurogenic bladder due to myelomenigocele. J of Ped Urol, 13(3): 271, 2017 - PubMed
-
- Bauer S, Joseph D : Management of the Obstructed urinary tract associated with neurogenic bladder dysfunction. Urol Clin North Amer, 17(2):395, 1990 - PubMed
MeSH terms
Grants and funding
- U01DD001092/ACL/ACL HHS/United States
- U01DD001068/ACL/ACL HHS/United States
- U01 DD001075/DD/NCBDD CDC HHS/United States
- U01 DD001064/DD/NCBDD CDC HHS/United States
- U01 DD001060/DD/NCBDD CDC HHS/United States
- U01DD001070/ACL/ACL HHS/United States
- U01 DD001092/DD/NCBDD CDC HHS/United States
- CC999999/ImCDC/Intramural CDC HHS/United States
- U01DD001060/ACL/ACL HHS/United States
- U01DD001058/ACL/ACL HHS/United States
- U01DD001064/ACL/ACL HHS/United States
- U01 DD001263/DD/NCBDD CDC HHS/United States
- U01 DD001087/DD/NCBDD CDC HHS/United States
- U01 DD001058/DD/NCBDD CDC HHS/United States
- U01 DD001276/DD/NCBDD CDC HHS/United States
- U01 DD001234/DD/NCBDD CDC HHS/United States
- U01DD001075/ACL/ACL HHS/United States
- U01 DD001079/DD/NCBDD CDC HHS/United States
- U01 DD001068/DD/NCBDD CDC HHS/United States
- U01 DD001265/DD/NCBDD CDC HHS/United States
- U01 DD001072/DD/NCBDD CDC HHS/United States
- U01DD001079/ACL/ACL HHS/United States
- U01DD001087/ACL/ACL HHS/United States
- U01 DD001070/DD/NCBDD CDC HHS/United States
- U01 DD001062/DD/NCBDD CDC HHS/United States
LinkOut - more resources
Full Text Sources
